
AP
APOC3-mediated dyslipidemia in kidney disease and atherosclerosis in diabetes
Jenny Kanter
NIDDK

AS
ASCEND: A Trial of Sertraline vs. CBT for End-Stage Renal Disease Patients with Depression
Rajnish Mehrotra
PCORI

AS
ASSESS-AKI: Assessment, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury
Jonathan Himmelfarb
NIDDK
Jonathan Himmelfarb, MD

Be
Best Case Worst Case: Effective Communication between Kidney Specialists and Their Patients
Daniel Lam
NIH

CA
CANDY CANE: Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease – Changing Glucose Management
Ian de Boer
ADA

CA
CANDY: Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease
Ian de Boer
ADA

CL
CLEAR: Clearance of 25-hydroxyvitamin D in Chronic Kidney Disease
Ian de Boer
NIDDK

CO
CONCORD: Combination of Novel Therapies for CKD Comorbid Depression
Rajnish Mehrotra
NIDDK

Co
CoNR: Cross-over Randomized Controlled Trial of Coenzyme Q10 or Nicotinamide Riboside in Chronic Kidney Disease
Bryan Kestenbaum
NIDDK

ED
EDEN-EPO Dosing for Anemia in End-Stage Kidney Disease
Jonathan Himmelfarb
NIH

ES
ESTEEM: Exercise Study Testing Enhanced Energetics of Muscle Mitochondria in Chronic Kidney Disease
Baback Roshanravan
NIDDK
Baback Roshanravan, MD

GL
GLUTE: Randomized Trial of Glutamine in Chronic Kidney Disease
Jonathan Himmelfarb
NIDDK / NY Medical College
Jonathan Himmelfarb, MD
Im
Improving Medical Decision Making for Older Patients with End Stage Renal Disease
Susan Wong

Ki
Kidney Tubular Functions in Type 1 Diabetes
Ian de Boer
NIDDK
Lo
Long-term Outcomes Associated With Implantable Cardioverter Defibrillator in Adults With Chronic Kidney Disease
Nisha Bansal
ME
MEND: Muscle Mitochondria Energetics in Chronic Kidney Disease
Bryan Kestenbaum
NIDDK

OK
OK-D: Association between retinal angiography findings and kidney histopathology in participants with diabetes
Christine Limonte

PE
PERLage: Preventing Early Renal Loss in Diabetes
Ian de Boer
Joslin Diabetes Center (Flow…
PR
PROCLAIM: Proximal Tubule Clearance of Renal Medications Study
Bryan Kestenbaum
NIDDK
Pr
Promoting goal concordant care among patients with advanced kidney disease
Susan Wong

RE
REMODEL-T1D
Ian de Boer
Breakthrough T1D

Sp
Spin-D: Safety and Cardiovascular Efficacy on Spironolactone in Hemodialysis Patients
Jonathan Himmelfarb
NIDDK
Jonathan Himmelfarb, MD